Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis

Eur Urol. 2016 Dec;70(6):1082-1083. doi: 10.1016/j.eururo.2016.05.040. Epub 2016 Jun 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Carcinoma, Renal Cell*
  • Humans
  • Kidney Failure, Chronic
  • Kidney Neoplasms*
  • Nivolumab


  • Antibodies, Monoclonal
  • Nivolumab